Clarivate Plc [CLVT] Revenue clocked in at $2.35 billion, down -60.08% YTD: What’s Next?

Clarivate Plc [NYSE: CLVT] gained 2.18% or 0.2 points to close at $9.39 with a heavy trading volume of 12878708 shares. The company report on September 28, 2022 that Clarivate to Report Third Quarter 2022 Results on November 8, 2022.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Announces plans for Investor Day in 2023.

Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the third quarter 2022 before the market opens on Tuesday, November 8. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at The Company will host a conference call and webcast on Tuesday, November 8 at 9:00 AM Eastern Time to review the results.

It opened the trading session at $9.17, the shares rose to $9.46 and dropped to $9.055, the range by which the price of stock traded the whole day. The daily chart for CLVT points out that the company has recorded -43.97% loss over the past six months. However, it is still -2.29% lower than its most recent low trading price.

If we look at the average trading volume of 5.80M shares, CLVT reached to a volume of 12878708 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Clarivate Plc [CLVT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLVT shares is $15.31 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLVT stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wells Fargo have made an estimate for Clarivate Plc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 13, 2022. While these analysts kept the previous recommendation, Citigroup dropped their target price from $35 to $16. The new note on the price target was released on February 04, 2022, representing the official price target for Clarivate Plc stock. Previously, the target price had yet another raise to $16, while Barclays analysts kept a Equal Weight rating on CLVT stock.

The Average True Range (ATR) for Clarivate Plc is set at 0.45, with the Price to Sales ratio for CLVT stock in the period of the last 12 months amounting to 2.63. The Price to Book ratio for the last quarter was 0.66, with the Price to Cash per share for the same quarter was set at 0.55. Price to Free Cash Flow for CLVT in the course of the last twelve months was 76.32 with Quick ratio for the last quarter at 0.80.

Trading performance analysis for CLVT stock

Clarivate Plc [CLVT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.21. With this latest performance, CLVT shares dropped by -19.54% in over the last four-week period, additionally sinking by -43.97% over the last 6 months – not to mention a drop of -57.12% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLVT stock in for the last two-week period is set at 27.66, with the RSI for the last a single of trading hit 26.30, and the three-weeks RSI is set at 30.16 for Clarivate Plc [CLVT]. The present Moving Average for the last 50 days of trading for this stock 12.30, while it was recorded at 9.54 for the last single week of trading, and 15.25 for the last 200 days.

Clarivate Plc [CLVT]: A deeper dive into fundamental analysis

Clarivate Plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.80 and a Current Ratio set at 0.80.

Clarivate Plc [CLVT]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLVT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clarivate Plc go to 14.60%.

An analysis of insider ownership at Clarivate Plc [CLVT]

There are presently around $5,288 million, or 98.40% of CLVT stock, in the hands of institutional investors. The top three institutional holders of CLVT stocks are: LEONARD GREEN & PARTNERS, L.P. with ownership of 116,666,507, which is approximately 0% of the company’s market cap and around 0.80% of the total institutional ownership; GENERATION INVESTMENT MANAGEMENT LLP, holding 46,298,600 shares of the stock with an approximate value of $434.74 million in CLVT stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $290.01 million in CLVT stock with ownership of nearly 0.081% of the company’s market capitalization.

138 institutional holders increased their position in Clarivate Plc [NYSE:CLVT] by around 54,884,057 shares. Additionally, 149 investors decreased positions by around 57,853,714 shares, while 29 investors held positions by with 450,377,007 shares. The mentioned changes placed institutional holdings at 563,114,778 shares, according to the latest SEC report filing. CLVT stock had 36 new institutional investments in for a total of 13,923,763 shares, while 33 institutional investors sold positions of 6,499,490 shares during the same period.


Please enter your comment!
Please enter your name here